May 9, 2017

Magellan Health to Present at Barclays Pharmacy Benefit Management & Drug Pricing Symposium

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) announced today that Mostafa Kamal, chief executive officer of Magellan Rx Management, the company's pharmacy benefit management division, will participate in a panel at the Barclays Pharmacy Benefit Management and Drug Pricing Symposium in New York on Thursday, May 25, 2017. The panel will discuss Innovation in Pharmacy Benefit Management.

About Magellan Health: Magellan Health, Inc. is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170509005493/en/

Magellan Health, Inc.

Media Contact:

Colleen Flanagan Johnson, 860-507-1923 cefjohnson@magellanhealth.com

or

Investor Contact:

Joe Bogdan, 860-507-1910 jbogdan@magellanhealth.com

Source: Magellan Health, Inc. News Provided by Acquire Media

Magellan Health Services Inc. published this content on 09 May 2017 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 11 May 2017 10:46:06 UTC.

Original documenthttp://ir.magellanhealth.com/common/download/download.cfm?companyid=ABEA-31T2WX&fileid=941826&filekey=5A4B3044-F929-4FB1-8027-085F08C00816&filename=MGLN_News_2017_5_9_General.pdf

Public permalinkhttp://www.publicnow.com/view/89F266A83D51E0C251AA39AEADDD51F33E4103B9